Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Staged Nutrition and Activity Counselling (SNAC) interventions that prime targeted antihypertensive therapy to prevent cardiovascular outcomes in the primary care setting
ISRCTN ISRCTN42921300
ClinicalTrials.gov identifier
Public title Staged Nutrition and Activity Counselling (SNAC) interventions that prime targeted antihypertensive therapy to prevent cardiovascular outcomes in the primary care setting
Scientific title
Acronym SNAC
Serial number at source N/A
Study hypothesis Improved lifestyle behaviour would enhance cardiac function, vascular elastic properties, and conduit vessel endothelial function with important benefits to clinical outcome measures and exercise perturbations to the cardiovascular system.
Lay summary Not provided at time of registration
Ethics approval Ethics approval received from the Research Ethics Board of The University of Western Ontario on the 22nd April 2003 (review #: 09572).
Study design Randomised prospective design.
Countries of recruitment Canada
Disease/condition/study domain High-normal blood pressure and/or impaired glucose regulation.
Participants - inclusion criteria 1. Men and women aged 40 - 85 years who are able to provide informed consent
2. Presence of high-normal blood pressure, impaired fasting glucose, impaired glucose tolerance, or all of them
Participants - exclusion criteria 1. Unstable cardiovascular or metabolic disease
2. Previous diagnosis of hypertension or type 2 diabetes
3. Myocardial infarction, coronary artery bypass, or cerebrovascular ischaemia/stroke (including Transient Ischaemic Attack [TIA]) within 3 months prior to study
4. History of alcoholism, drug abuse, or other emotional, cognitive or psychiatric problems that are likely to limit compliance to the study
5. Pacemaker
6. Already enrolled in a clinical research trial
Anticipated start date 01/01/2004
Anticipated end date 30/06/2006
Status of trial Completed
Patient information material
Target number of participants 300
Interventions Subjects were randomly assigned to either the SNAC intervention group or the usual care group.

The SNAC intervention group received the SNAC lifestyle intervention that combined the STEP test and exercise prescription with a version of Canada’s Food Guide adapted to suit a Mediterranean-style diet. The SNAC lifestyle intervention was delivered according to Procheska and Declemente’s Transtheoretical Model, and delivered by each subject’s family physician. To optimise familiarisation with the diet and facilitate long-term adherence, during first 8 weeks, subjects received one dinner meal per day (5 meals per week) from the laboratory as well as sample menus for breakfast and lunch. From the week 9, subjects received only sample menus for all meals.

The usual care group received "usual care" blood pressure and plasma glucose management from their family physician (for example, family physicians in this group delivered lifestyle advise to subjects as the way they normally did).

All assessments were conducted at baseline (V1), week 8 (V2), week 16 (V3), week 24 (V4), and week 52 (V5).
Primary outcome measure(s) Improvements in exercise capacity, left ventricular diastolic function (E/A ratio), and brachial artery endothelial function, measured at V1 - V5 (see interventions).
Secondary outcome measure(s) 1. Caloric profile and anthropometrics, measured at V1 - V5 (see interventions)
2. Resting blood pressure and 24-hour ambulatory blood pressure, measured at V1 - V5
3. Blood chemistries (glucose, lipids, catecholamines, HbA1c, etc), measured at V1 - V5
4. Muscle sympathetic nerve activity, measured at V1 - V5
5. Geometry and elastic properties of the carotid artery, and geometry of left ventricle, measured at V1 - V5
Sources of funding Heart and Stroke Foundation of Ontario (Canada)
Trial website
Publications 1. 2011 protocol in http://www.ncbi.nlm.nih.gov/pubmed/21324150
Contact name Dr  Robert  Petrella
  Address Parkwood Hospital, Room B3002
801 Commissioners Rd. E
  City/town London
  Zip/Postcode N6C 5J1
  Country Canada
  Email petrella@uwo.ca
Sponsor Lawson Health Research Institute (Canada)
  Address 801 Commissioners Rd. E
  City/town London
  Zip/Postcode N6C 5J1
  Country Canada
  Email info@lhrionhealth.ca
  Sponsor website: http://www.lhrionhealth.ca/LHRI/index.html
Date applied 11/12/2007
Last edited 11/01/2012
Date ISRCTN assigned 19/12/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central